Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00570752

Contacts


Contact: For participation information at a USA site use a phone number below. For site information outside the USA please email:		Clinical.Trials@bms.com

Contact: First line of email MUST contain NCT# & Site#. Only trial sites that are recruiting have contact information at this time.

Locations


United States, Maine
	Local Institution	Not yet recruiting
	Scarborough, Maine, United States, 04074
	Contact: Site 003

United States, Massachusetts
	Local Institution	Not yet recruiting
	Boston, Massachusetts, United States, 02114
	Contact: Site 001

United States, Michigan
	Local Institution	Not yet recruiting
	Royal Oak, Michigan, United States, 48073
	Contact: Site 007

United States, New York
	Local Institution	Not yet recruiting
	New York, New York, United States, 10029
	Contact: Site 002

United States, North Carolina
	Local Institution	Not yet recruiting
	Statesville, North Carolina, United States, 28677
	Contact: Site 008

United States, Ohio
	Metabolic And Atherosclerosis Research Center	Recruiting
	Cincinnati, Ohio, United States, 45212
	Contact: Evan A. Stein, Site 006

Sponsors and Collaborators

Bristol-Myers Squibb

Investigators


Study Director:	Bristol-Myers Squibb	Bristol-Myers Squibb